PURPOSE: The development and implementation of a pharmacist-managed clinical pharmacogenetics service are described. SUMMARY: A pharmacist-managed clinical pharmacogenetics service was designed and implemented at an academic specialty hospital to provide clinical pharmacogenetic testing for gene products important to the pharmacodynamics of medications used in the hospital's patients. A series of accredited educational seminars were conducted for our pharmacists to establish competencies in providing pharmacogenetic consults for the genes to be tested by the clinical pharmacogenetics service. The service was modeled after and integrated with an already-established clinical pharmacokinetics service. A steering committee was formed to evaluate the use of available tests, new evidence for implementation of additional tests, and other service quality metrics. All clinical pharmacogenetic test results are first reported to one of the pharmacists, who reviews the result and provides a written consultation. The consultation includes an interpretation of the result and recommendations for any indicated changes to therapy. In 2009, 136 clinical pharmacogenetic tests were performed. The service has been met with positive clinician feedback. The successful implementation of this service highlights the leadership role that pharmacists can take in moving pharmacogenetics from research to patient care. CONCLUSION: The development of and experience with a pharmacist-managed clinical pharmacogenetics service are described. The program's success has depended on collaboration between the clinical laboratory and pharmacists, and pharmacists' pharmacogenetic recommendations have been well accepted by prescribers.
PURPOSE: The development and implementation of a pharmacist-managed clinical pharmacogenetics service are described. SUMMARY: A pharmacist-managed clinical pharmacogenetics service was designed and implemented at an academic specialty hospital to provide clinical pharmacogenetic testing for gene products important to the pharmacodynamics of medications used in the hospital's patients. A series of accredited educational seminars were conducted for our pharmacists to establish competencies in providing pharmacogenetic consults for the genes to be tested by the clinical pharmacogenetics service. The service was modeled after and integrated with an already-established clinical pharmacokinetics service. A steering committee was formed to evaluate the use of available tests, new evidence for implementation of additional tests, and other service quality metrics. All clinical pharmacogenetic test results are first reported to one of the pharmacists, who reviews the result and provides a written consultation. The consultation includes an interpretation of the result and recommendations for any indicated changes to therapy. In 2009, 136 clinical pharmacogenetic tests were performed. The service has been met with positive clinician feedback. The successful implementation of this service highlights the leadership role that pharmacists can take in moving pharmacogenetics from research to patient care. CONCLUSION: The development of and experience with a pharmacist-managed clinical pharmacogenetics service are described. The program's success has depended on collaboration between the clinical laboratory and pharmacists, and pharmacists' pharmacogenetic recommendations have been well accepted by prescribers.
Authors: Dan M Roden; Russ B Altman; Neal L Benowitz; David A Flockhart; Kathleen M Giacomini; Julie A Johnson; Ronald M Krauss; Howard L McLeod; Mark J Ratain; Mary V Relling; Huijun Z Ring; Alan R Shuldiner; Richard M Weinshilboum; Scott T Weiss Journal: Ann Intern Med Date: 2006-11-21 Impact factor: 25.391
Authors: M V Relling; M L Hancock; G K Rivera; J T Sandlund; R C Ribeiro; E Y Krynetski; C H Pui; W E Evans Journal: J Natl Cancer Inst Date: 1999-12-01 Impact factor: 13.506
Authors: Clinton F Stewart; John C Panetta; Melinda A O'Shaughnessy; Stacy L Throm; Charles H Fraga; Thandranese Owens; Tiebin Liu; Catherine Billups; Carlos Rodriguez-Galindo; Amar Gajjar; Wayne L Furman; Lisa M McGregor Journal: J Clin Oncol Date: 2007-06-20 Impact factor: 44.544
Authors: G Stocco; M H Cheok; K R Crews; T Dervieux; D French; D Pei; W Yang; C Cheng; C-H Pui; M V Relling; W E Evans Journal: Clin Pharmacol Ther Date: 2008-08-06 Impact factor: 6.875
Authors: Felix W Frueh; Shashi Amur; Padmaja Mummaneni; Robert S Epstein; Ronald E Aubert; Teresa M DeLuca; Robert R Verbrugge; Gilbert J Burckart; Lawrence J Lesko Journal: Pharmacotherapy Date: 2008-08 Impact factor: 4.705
Authors: Christine M Formea; Wayne T Nicholson; Kristen B McCullough; Kevin D Berg; Melody L Berg; Julie L Cunningham; Julianna A Merten; Narith N Ou; Joanna L Stollings Journal: Am J Pharm Educ Date: 2013-02-12 Impact factor: 2.047